Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 17591808)

Published in Ann Oncol on June 01, 2007

Authors

G Badalamenti1, V Rodolico, F Fulfaro, S Cascio, C Cipolla, G Cicero, L Incorvaia, M Sanfilippo, C Intrivici, L Sandonato, G Pantuso, M A Latteri, N Gebbia, A Russo

Author Affiliations

1: Section of Medical Oncology, Università di Palermo, Italy.

Articles by these authors

The fission yeast cdc18+ gene product couples S phase to START and mitosis. Cell (1993) 6.25

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36

Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol (2007) 3.26

The formation and maintenance of the definitive endoderm lineage in the mouse: involvement of HNF3/forkhead proteins. Development (1993) 3.22

Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81

High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol (1999) 2.80

Reconstitution of simian virus 40 DNA replication with purified proteins. Proc Natl Acad Sci U S A (1990) 2.32

Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13

Overexpression of folate binding protein in ovarian cancers. Int J Cancer (1997) 2.13

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol (1995) 2.09

HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol (2008) 1.99

Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98

Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98

Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95

Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res (1993) 1.88

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut (2005) 1.84

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol (2012) 1.79

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol (2002) 1.74

On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells. Proc Natl Acad Sci U S A (1986) 1.72

Biologically active metal-independent superoxide dismutase mimics. Biochemistry (1990) 1.72

Factors affecting in-hospital heat-related mortality: a multi-city case-crossover analysis. J Epidemiol Community Health (2008) 1.70

Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol (2003) 1.69

Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68

Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64

Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound. Gut (1998) 1.64

Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. J Natl Cancer Inst (1995) 1.63

Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest (1983) 1.59

Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem (1996) 1.59

In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol (2010) 1.58

Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol (1994) 1.56

Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial. Cancer (1994) 1.55

Petrous bone cholesteatoma. Skull Base Surg (1993) 1.55

The impact of the summer 2003 heat waves on mortality in four Italian cities. Euro Surveill (2005) 1.55

Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A (1992) 1.54

Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys (1991) 1.53

Systematic review: green tea and gastrointestinal cancer risk. Aliment Pharmacol Ther (2004) 1.49

The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci (2005) 1.48

The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage (2000) 1.47

Left atrial thrombus and spontaneous echo-contrast in nonanticoagulated mitral stenosis. A transesophageal echocardiographic study. Chest (1993) 1.43

Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene (2008) 1.42

[Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases]. J Fr Ophtalmol (2013) 1.40

Antithrombotic drugs in secondary stroke prevention among a community dwelling older population. J Neurol Neurosurg Psychiatry (2003) 1.40

Facial nerve neuromas: diagnosis and management. Am J Otol (1995) 1.40

Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease. J Endocrinol Invest (2004) 1.39

Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile? Dig Liver Dis (2000) 1.39

Leukocyte alkaline phosphatase (LAP). A useful marker of zinc status in beta-thalassemic patients. Am J Pediatr Hematol Oncol (1987) 1.38

Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Ital J Gastroenterol Hepatol (1997) 1.38

Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem (1997) 1.37

Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA (1999) 1.37

Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer (1998) 1.36

Breast cancer genome-wide association studies: there is strength in numbers. Oncogene (2011) 1.34

Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol (2006) 1.33

Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem (1996) 1.33

Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia (2002) 1.33

Myringoplasty in children: factors influencing surgical outcome. Otolaryngol Head Neck Surg (1998) 1.29

Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol (2002) 1.29

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Ann Oncol (2012) 1.28

Large-scale spatial distribution of virioplankton in the Adriatic Sea: testing the trophic state control hypothesis. Appl Environ Microbiol (2003) 1.28

Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res (1986) 1.27

A novel metal-free low molecular weight superoxide dismutase mimic. J Biol Chem (1988) 1.26

Pain management in frail, community-living elderly patients. Arch Intern Med (2001) 1.26

In vivo imaging of a stable paramagnetic probe by pulsed-radiofrequency electron paramagnetic resonance spectroscopy. Magn Reson Med (1997) 1.26

Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer (2001) 1.26

Photodynamic therapy. J Clin Oncol (1988) 1.25

Discriminative and predictive power of an informant report in mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.25

Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care (1998) 1.24

Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer (2001) 1.21

Impact of in situ chemical oxidation on contaminant mass discharge: linking source-zone and plume-scale characterizations of remediation performance. Environ Sci Technol (2011) 1.21

Initiation of SV40 DNA replication: mechanism and control. Cold Spring Harb Symp Quant Biol (1991) 1.21

Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord (1997) 1.21

Characterizing long-term contaminant mass discharge and the relationship between reductions in discharge and reductions in mass for DNAPL source areas. J Contam Hydrol (2013) 1.21

Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. Ann Oncol (2005) 1.21

Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur J Clin Invest (1998) 1.21

Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol (1997) 1.19

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol (2001) 1.17

The role of Aurora-A inhibitors in cancer therapy. Ann Oncol (2007) 1.16

Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer (2000) 1.16

Bowel frequency in healthy children. Acta Paediatr Scand (1989) 1.16

Mastoidectomy in noncholesteatomatous chronic suppurative otitis media: is it necessary? Otolaryngol Head Neck Surg (1997) 1.15

Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther (2006) 1.14

A novel route in bone tissue engineering: magnetic biomimetic scaffolds. Acta Biomater (2009) 1.14

In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Environ Mol Mutagen (2000) 1.13

Reproducibility of histologic classification of gastric cancer. Br J Cancer (1991) 1.13

Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2000) 1.13

Development and clinical assessment of an artificial cornea. Prog Retin Eye Res (2000) 1.13

The role of glutathione in radiation and drug induced cytotoxicity. Br J Cancer Suppl (1987) 1.12

Superoxide reaction with nitroxide spin-adducts. Free Radic Biol Med (1989) 1.12